Medicare Select Program Extending By House

20 August 1995

In the USA, the House of Representatives early last month passed a bill extending the Medicare Select program which will now allow seniors in all 50 states to buy extra Medicare coverage at a discount by agreeing to use managed care. Since 1992, the policies have been sold in just 25 states. A similar bill has already been passed by the Senate (Marketletters passim) and President Clinton is expected to sign the measure.

Since then, White House officials have criticized House Speaker Newt Gingrich's claim that they were trying to scare the elderly with false claims about the Republican's proposals to save money on Medicare; the officials said the Republican plan would cost Medicare beneficiaries even more than they had originally estimated.

OMB Assessment The White House officials released an Office of Management and Budget analysis assessing a list of Republican options to trim projected Medicare spending by $270 billion over the next seven years.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight